Picture of Humacyte logo

HUMA — Humacyte News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

U.S. STOCKS ON THE MOVE-Interactive Strength, KeyCorp, Humacyte

* 
      Eikon search string for individual stock moves:  STXBZ 
    

        * 
      The Day Ahead newsletter: https://refini.tv/3LI4BU7
    

        * 
      The Morning News Call newsletter: https://refini.tv/3dKUyB8
    

  
U.S. stock index futures were marginally higher on Monday as investors braced
for a data-packed week, with focus on U.S. consumer prices that could provide
strong cues about the Federal Reserve's interest-rate move in September.  .N 
    
    At 7:46 ET, Dow e-minis  1YMc1  were up 0.13% at 39,690. S&P 500 e-minis
 ESc1  were up 0.20% at 5,380.75, while Nasdaq 100 e-minis  NQc1  were up 0.18%
at 18,649.25.
 
 The top three NYSE percentage gainers premarket  .PRPG.NQ :
 ** Keycorp  KEY , up 16.6%
 ** Allurion Technologies  ALUR.K , up 11.4%
 ** Ampco-Pittsburgh  AP , up 11.0%
 
 The top three NYSE percentage losers premarket  .PRPL.NQ :
 ** Enerflex  EFXT.K , down 16.9%
 ** Orion Group  ORN , down 15.6%
 ** On24  ONTF.K , down 14.9%
 
 The top Nasdaq percentage gainer premarket  .PRPG.O :
 ** Interactive Strength Inc  TRNR.O , up 122.2%
 
 ** Humacyte Inc  HUMA.O : down 10.7% premarket
 BUZZ - Falls after US FDA extends review of co's blood vessel implant
 urn:newsml:reuters.com:*:nL4N3JZ0EO 

 ** Starbucks Corp  SBUX.O : up 2.3% premarket
 BUZZ - Gains after report Starboard Value takes stake  urn:newsml:reuters.com:*:nL4N3JZ0FO 
    
 ** Hawaiian Electric Industries Inc  HE.N : down 9.7% premarket
 BUZZ - Falls after raising going concern doubts  urn:newsml:reuters.com:*:nL4N3JZ0G0 
    
 ** KeyCorp  KEY.N : up 16.6% premarket
 BUZZ - Scotiabank to buy minority stake in KeyCorp, shares rise  urn:newsml:reuters.com:*:nL4N3JZ0K1 
    
 ** Barrick Gold Corp  GOLD.N : up 2.3% premarket
 BUZZ - Rises after upbeat second-quarter profit  urn:newsml:reuters.com:*:nL4N3JZ0JW 

 (Compiled by Rajarshi Roy and Anshuman Tripathy)
 ((Rajarshi.Roy@thomsonreuters.com))

Recent news on Humacyte

See all news